Wang, B. Bevacizumab combined with chemotherapy and anti-PD-1 therapy for the first-line treatment of previously untreated metastatic triple-negative breast cancer. BMJ Publishing Group.
Chicago Style (17th ed.) CitationWang, Bi-Cheng. Bevacizumab Combined with Chemotherapy and Anti-PD-1 Therapy for the First-line Treatment of Previously Untreated Metastatic Triple-negative Breast Cancer. BMJ Publishing Group.
MLA (9th ed.) CitationWang, Bi-Cheng. Bevacizumab Combined with Chemotherapy and Anti-PD-1 Therapy for the First-line Treatment of Previously Untreated Metastatic Triple-negative Breast Cancer. BMJ Publishing Group.
Warning: These citations may not always be 100% accurate.